ABSTRACT-Murine macrophages are activated by interferon-γ (IFN-γ) and/or Toll-like receptor (TLR) agonists such as bacterial endotoxin (lipopolysaccharide [LPS]) to express an inflammatory (M1) phenotype characterized by the expression of nitric oxide synthase-2 (iNOS) and inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin (IL)-12. In contrast, Th2 cytokines IL-4 and IL-13 activate macrophages by inducing the expression of arginase-1 and the anti-inflammatory cytokine IL-10 in an IL-4 receptor-α (IL-4Rα)-dependent manner. Macrophages activated in this way are designated as "alternatively activated" (M2a) macrophages. We have shown previously that adenosine A 2A receptor (A 2A R) agonists act synergistically with TLR2, TLR4, TLR7, and TLR9 agonists to switch macrophages into an "M2-like" phenotype that we have termed "M2d." Adenosine signaling suppresses the TLRdependent expression of TNF-α, IL-12, IFN-γ, and several other inflammatory cytokines by macrophages and induces the expression of vascular endothelial growth factor (VEGF) and IL-10. We show here using mice lacking a functional IL-4Rα gene (IL-4Rα −/− mice) that this adenosine-mediated switch does not require IL-4Rα-dependent signaling. M2d macrophages express high levels of VEGF, IL-10, and iNOS, low levels of TNF-α and IL-12, and mildly elevated levels of arginase-1. In contrast, M2d macrophages do not express Ym1, Fizz1 (RELM-α), or CD206 at levels greater than those induced by LPS, and dectin-1 expression is suppressed. The use of these markers in vivo to identify "M2" macrophages thus provides an incomplete picture of macrophage functional status and should be viewed with caution.
INTRODUCTION
Macrophages play key roles in regulating inflammation, wound healing, and innate and acquired immunity [1] [2] [3] [4] . They are professional phagocytes equipped with cell surface and cytosolic receptors that enable them to recognize, phagocytize, and destroy foreign organisms, as well as dead or damaged host cells and tissue components [4] . In response to a variety of stimuli, macrophages produce select arrays of products that mediate various aspects of inflammation, wound healing, and innate and acquired immunity [5] . The expression of these mediators is closely regulated by microenvironmental influences [5, 6] . Macrophages are recruited from precursor monocytes in the circulation, which in turn derive from stem cells in the embryo and bone marrow [5, 7] . While distinct subpopulations of monocytes may exist, once recruited to a site of injury or infection, these monocytes differentiate into macrophages, and their expression of cell surface receptors, cytokines, growth and angiogenic factors, and other mediators of inflammation and repair is regulated by microenvironmental signals at the site of recruitment [5] [6] [7] .
Macrophage activation has been classified recently into "classical" and "alternative" activation pathways [5] [6] [7] . Classical activation is induced by interferon-γ (IFN-γ) with a variety of Toll-like receptor (TLR) agonists or by these agonists alone and is canonically described as featuring strong expression of inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, and IL-12, stimulation of the respiratory burst through activation of membrane oxidases, and induction of nitric oxide synthase-2 (iNOS) expression. Macrophages activated in this way have been termed M1 macrophages [5, 8] . "Alternative" activation is canonically defined as that induced by IL-4 and/or IL-13 through activation of the common IL-4Rα subunit of the receptors for these cytokines [1] . These "alternatively activated" macrophages have been termed M2 macrophages and are characterized in the mouse by elevated expression of anti-inflammatory cytokines and by elevated expression of CD206, Ym1, Fizz1 (RELM-α), dectin-1, and arginase-1 [5, [8] [9] [10] [11] . These markers, in conjunction with the expression of the panmacrophage markers F4/80 and CD68, have been commonly used in mouse studies to identify M1 vs M2 macrophage populations. While this broad classification, which bears parallels with the Th1/Th2 paradigm for activation of the immune system, has some utility, it has become clear recently that there are other modes for the regulation of macrophage phenotype and the broad use of the M2 classification may no longer be adequate. Additional subclassification of M2 macrophages into M2a, M2b, and M2c categories has been proposed. M2a refers to IL-4Rα-dependent activation; M2b refers to activation by immune complexes with or without TLR agonists; M2c refers to activation by TGF-β [12] . We have described an activation paradigm that differs from these prototypical M1 and M2 pathways and involves activation by TLR agonists in the presence of adenosine A 2A receptor (A 2A R) agonists [13] . This pathway switches macrophages from an M1 phenotype to an angiogenic "M2-like" phenotype that we have termed M2d [14] . The classical M2 (M2a) pathway is IL-4Rα-dependent, and the IL-4Rα-dependent markers CD206, Ym1, Fizz1, dectin-1, and arginase-1 have been used in several studies to indicate the presence of M2 macrophages. In this study, we examined the phenotype of M2d macrophages to determine (1) the expression levels of the canonical M2 markers CD206, Ym1, Fizz1, dectin-1, and arginase-1 and (2) whether the induction of the M2d phenotype requires signaling through the IL-4Rα signaling pathway.
MATERIALS AND METHODS

Preparation of Macrophages
Mouse peritoneal macrophages were harvested as previously described [13] . Briefly, 7-to 12-week-old male mice were injected intraperitoneally with 2.5 ml of 4 % thioglycollate broth (Difco, Detroit, MI, USA). Four days postinjection, mice were sacrificed by cervical dislocation and peritoneal macrophages were harvested and cultured as a monolayer in RPMI 1640 medium (Cellgro, Mediatech Inc., Herndon, VA, USA), supplemented with 10 % fetal bovine serum (FBS) (Gemini Bio-Products, Calabasas, CA, USA), 2 mMLglutamine, 100 IU/ml penicillin, and 100 μg/ml streptomycin (Irvine Scientific, Santa Ana, CA, USA). Monolayers were washed 4 h after plating to remove any nonadherent cells. The cultures were shown to be >98 % pure macrophages, as assessed by nonspecific esterase staining and staining with the macrophage-specific F4/ 80 mAb. The following strains of mice were used for these experiments: IL-4Rα mice homozygous for the Il4ra tm1Sz targeted mutation (IL-4Rα −/− mice) on the BALB/c background (BALB/c-IL4ra tm1Sz /J) were from Jackson Laboratory (Bar Harbor, ME, USA). Wild-type (WT) BALB/c mice were also from Jackson Laboratory.
Extraction of RNA and qRT-PCR
Mouse peritoneal macrophages were plated in 60-mm dishes at a density of 5-10×10 6 cells per dish. Following overnight incubation, cells were treated with various reagents as indicated in the figure legends. RNA was isolated using Trizol reagent (Invitrogen Corp., Carlsbad, CA, USA), according to the manufacturer's protocol for the isolation of total RNA from animal cells. cDNA was synthesized from 1 μg total RNA using TaqMan RT reagents (Applied Biosystems, Foster City, CA, USA) following the manufacturer's instructions. Quantitative real-time polymerase chain reactions (qRT-PCRs) were performed in an ABI Prism 7500 sequence detector using 1:10 volume of each cDNA reaction and TaqMan Universal PCR Master Mix. TaqMan gene expression assays for murine AR (Mm00802075_m1) and murine cyclophilin D (Mm00835365_g1) were purchased from Applied Biosystems. RT-PCRs were carried out using the manufacturer's protocol, and mRNA levels were determined using both relative and absolute quantification. PCRs were performed in duplicate, and expression levels for the transcripts of interest were normalized to that of endogenous cyclophilin D. Prior studies have indicated that cyclophilin D expression levels show minimal variation under the various activation conditions used in these experiments. Data were calculated as fold expression relative to the average of the untreated control group.
Flow Cytometry Analysis of Macrophage Marker Expression
Fluorescence-activated cell sorting (FACS) analysis was used to determine the expression levels of various macrophage markers. Macrophages were incubated at 4°C for 20-30 min to allow detachment from UpCell™ culture dishes (Nunc). UpCell™ dishes are coated with a polymer that shifts from hydrophobic to hydrophilic below 32°C, thereby facilitating macrophage detachment without chemical or mechanical manipulation. Macrophages were pelleted at 400×g at 4°C for 15 min, washed twice with sterile phosphate-buffered saline (PBS)(-Ca , and 4 μl RPE-conjugated antimouse dectin-1 (AbD Serotec). Macrophages were washed three times with 1 % FBS-PBS, resuspended in 100 μl fixation buffer (eBioscience), and incubated in darkness at room temperature for 20 min. After fixation, macrophages were washed three times with permeabilization buffer (eBioscience), resuspended in 100 μl permeabilization buffer, and incubated in darkness at room temperature for 20 min with 4 μl AlexaFluor 700-conjugated antimouse CD68 (AbD Serotec), 2.5 μl rabbit polyclonal antimouse Ym1 (Stem Cell Technologies), and 2.5 μl rabbit polyclonal antimouse RELM-α (Fizz1) (Abcam). Macrophages were washed three times with 1 % FBS-PBS, resuspended in 100 μl permeabilization buffer, and incubated in darkness at room temperature for 20 min with 1.5 μl AlexaFluor 488-conjugated antirabbit IgG (1:100 dilution; Invitrogen). Macrophages were washed three times with 1 % FBS-PBS and resuspended in 1 % FBS-PBS. Samples were analyzed using an LSR II flow cytometer (Becton Dickinson) and FlowJo software (Treestar Inc., Ashland, OR, USA).
Cytokine Assays
Macrophages were plated in 12-well plates at a density of 0.5 × 10 6 cells per well. Posttreatment, macrophage-conditioned media were collected and levels of TNF-α (eBioscience), a typical M1 cytokine, and vascular endothelial growth factor (VEGF) (R&D Systems), a typical M2d cytokine, were quantified by enzyme-linked immunosorbent assay (ELISA) performed according to the manufacturers' instructions. Samples were assayed in duplicate and normalized to relative cell number as determined by MTT assay. Levels of other cytokines in the conditioned media were analyzed in duplicate using the premixed 32-plex Milliplex™ MAP Mouse Cytokine/ Chemokine Immunoassay Kit (Millipore Corporation, Billerica, MA, USA) following the recommended protocol for tissue culture supernatant. Fluorescence was measured using the Luminex 100 xMAP Technology System (Luminex Corporation, Austin, TX, USA), and data were analyzed in Luminex 100 Integrated System Software 2.3 (Luminex Corporation, Austin, TX, USA) using a four-parameter logistic curve fit.
Statistical Analyses
Values in the figures are expressed as the means ± standard deviation (SD). Statistical analysis of the data was performed using Student's t test or one-way analysis of variance followed by Dunnett's test as appropriate.
RESULTS
IL-4Rα Signaling is not Required for M2d Macrophage Polarization
To examine the contribution of IL-4Rα signaling to M2d macrophage polarization, we first examined cytokine and growth factor secretion by macrophages from WT and IL-4Rα −/− mice ( Figs. 1 and 2 ). Stimulation of macrophages by lipopolysaccharide (LPS) strongly induced the secretion of TNF-α, a typical proinflammatory cytokine, in both WT and IL-4Rα −/− mice (Fig. 1a) . In contrast, treatment of WT and IL-4Rα Further analysis of cytokine production in WT and IL-4Rα −/− macrophages using Luminex technology (Fig. 2 ) showed that several cytokines in addition to TNF-α and VEGF were modulated by the adenosine receptor agonist NECA. Expression of IFN-γ, IL-12, IL-1α, IL-1β, MIP-1β, and MCP-1, which are generally associated with a proinflammatory state, was markedly suppressed when LPStreated macrophages were compared to macrophages treated in conjunction with NECA. On the other hand, IL-10 and G-CSF that are generally considered to be antiinflammatory were increased. Overall, changes in cytokine release during induction of the M2d phenotype were similar in both WT and IL-4Rα −/− macrophages, further validating the independence of the M2d phenotype from the M2a IL-4Rα-dependent signaling. However, a notable difference in the expression of IFN-γ between WT and IL-4Rα −/− macrophages was seen (Fig. 2b) . IFN-γ is generally considered a signature cytokine of Th1 cells. It is thus interesting that macrophages from IL-4Rα −/− mice expressed lower levels of IFN-γ in response to LPS than WT macrophages (Fig. 2b) . IFN-γ expression by WT macrophages was also strongly suppressed by NECA treatment.
Expression of M2a Macrophage Markers Differs from that of M2d Macrophages
Alternative activation of murine macrophages (IL-4Rα-dependent, M2a) has been shown in prior studies to enhance the expression of several genes now considered canonical markers for the M2 phenotype, including arginase-1, Ym1, Fizz1, CD206, and dectin-1. Expression of these markers has been studied on murine macrophage populations in several in vivo models of inflammation and has been taken to indicate the presence of "alternatively activated" M2 macrophages. We have examined the in vitro expression of these markers, as well as of iNOS, a typical marker of M1 macrophage polarization, by peritoneal macrophages treated to induce M1, M2a, or M2d polarization (Figs. 3, 4 , and 5). with LPS (100 ng/ml), LPS with NECA (1 μM), or IL-4 (10 ng/ml). Cytokine/chemokine levels were assayed from three replicate samples from each condition, and each sample was assayed in triplicate using Milliplex™ MAP immunoassays. Mean ± SD for each sample is presented.
iNOS
Treatment with LPS alone dramatically elevated mRNA levels of the M1 macrophage marker iNOS and this level was augmented by concurrent treatment with NECA (Fig. 3a) . This pattern was also observed in IL-4Rα −/− macrophages and was maintained in WT macrophages even with the presence of IL-4 in the external milieu.
Arginase
Increased arginase mRNA expression was observed in M2a macrophages compared to M2d-polarized macrophages (Fig. 3b) . Stimulation of adenosine receptors with NECA, in conjunction with IL-4 to induce the M2a phenotype, markedly increased arginase-1 expression over that induced by IL-4 alone, as we have reported previously [15] . This increase is unlike the expression patterns observed with Ym1, Fizz1, and CD206 (see the next subsection). Interestingly, the activation of TLR receptor signaling by LPS in the presence of IL-4 abrogated the increased arginase mRNA levels seen with IL-4 treatment alone. Stimulation of IL-4/NECAtreated cells with LPS also suppressed arginase-1 expression, although to a lesser extent than that induced in cells treated with IL-4 alone. The effects observed in WT cells in the presence of IL-4R activation were absent in IL-4Rα −/− macrophages.
Ym1/Fizz1/CD206
Markedly different expression patterns of M2 markers were observed in M2a-polarized and M2d-polarized peritoneal macrophages (Figs. 4 and 5) . Ym1 protein and mRNA expression was increased in WT but not IL-4Rα −/− macrophages upon induction of the M2a phenotype by IL-4; however, in response to M2d stimulation (LPS/NECA), Ym1 protein and mRNA levels remained unchanged in both WT and IL-4Rα −/− macrophages. While changes in Fizz1 and CD206 were not observable at the protein level by flow cytometry (data not shown), mRNA levels of these M2 markers demonstrated the same pattern as seen with Ym1 (Fig. 5b, c) . Furthermore, as observed with the cytokines TNF-α and VEGF, treatment with IL-4 had no effect on the protein and mRNA levels of these markers in M2d macrophages.
Dectin-1
Both WT and IL-4Rα
−/− macrophages treated with LPS and NECA to induce the M2d phenotype exhibited significantly downregulated surface expression of the M2 marker dectin-1 (Fig. 4) . In contrast, WT but not IL-4Rα −/− macrophages, polarized toward the M2a phenotype by exposure to IL-4, exhibited a small increase in dectin-1 surface expression. Treatment of WT macrophages with a combination of LPS, NECA, and IL-4 resulted in dectin-1 surface expression that mirrored that seen upon stimulation with LPS and NECA alone.
Regulation of IL-4Rα Expression Differs in M2a-Polarized and M2d-Polarized Macrophages
Flow cytometric analysis of IL-4Rα surface expression in M2a and M2d macrophages revealed yet another divergence in the protein expression profile of these distinctively polarized macrophages. While stimulation of WT macrophages with IL-4 led to a substantial abatement of IL-4Rα on the cell surface, induction of the M2d phenotype with LPS and NECA increased IL-4Rα surface expression (Fig. 4) . IL-4Rα surface expression in response to concurrent stimulation with LPS, NECA, and IL-4 mimicked that observed in M2a polarization, i.e., downregulation of surface dectin-1 expression (Fig. 4) .
As expected, IL-4Rα
−/− macrophages demonstrated no surface IL-4Rα expression (Fig. 4) .
Regulation of A 2A R Expression is Similar in WT and IL-4Rα
−/− Macrophage Activation
Previous studies have shown the upregulation of A 2A Rs in macrophages activated by LPS stimulation [16] [17] [18] [19] . This upregulation is believed to sensitize macrophages to adenosine signaling by priming M1 macrophages to respond to adenosine and thus switching toward the M2d phenotype. As shown in Fig. 6 , LPS activation of both WT and IL-4Rα −/− macrophages strongly induced A 2A R expression, demonstrating that the induction of A 2A Rs by LPS is independent of IL-4Rα signaling.
DISCUSSION
Macrophages comprise a diverse population of cells and demonstrate remarkable functional plasticity in response to dynamic microenvironmental cues. "Classical" (M1) activation of macrophages is induced by TLR agonists, either with or without the Th1 cytokine IFN-γ, and results in an inflammatory phenotype characterized by expression of a series of inflammatory cytokines and chemokines, including TNF-α, IL-1β, IL-6, MIP-1α, and IL-12 [5, 8] . "Alternatively activated" (M2) macrophages were originally described as induced by the Th2 cytokines IL-4 and IL-13 through the IL-4Rα subunit common to the receptors for these cytokines, leading to the expression of an , right panels) mice treated for 18 h with LPS (100 ng/ml) and NECA (1 μM) (black), IL-4 (10 ng/ml) (red), or a combination of all three (black dotted), as described in the "Materials and Methods" section. Cells were analyzed for the expression of Ym1 (upper panels), dectin-1 (middle panels), and IL-4Rα (lower panels). Shaded histograms represent marker expression in untreated controls. b Analysis of Ym1, dectin-1, and IL-4Rα expression determined by FACS in treated vs untreated macrophages. Results indicate mean fold differences of median fluorescence values by treated macrophages vs controls from three independent experiments.
anti-inflammatory and wound healing phenotype [1, 5, 8] . This IL-4Rα-dependent phenotype has been termed "M2a" [12] . Several recent studies have examined macrophage subpopulations in vivo using markers of the M2a phenotype to distinguish M1 from M2 macrophages [3, [20] [21] [22] [23] [24] .
We have proposed a model for the induction of an M2-like macrophage phenotype that we have termed "M2d" [14] . This model involves the initial activation of macrophages by TLR agonists, which strongly induce the expression of adenosine A 2A and A 2B receptors −/− mice were treated for 6 h with LPS (100 ng/ml), NECA (1 μM), or IL-4 (10 ng/ml), alone and in combination, as indicated. mRNA levels of canonical M2 markers Ym1 (a), Fizz1 (b), and CD206 (c) were evaluated using qRT-PCR. Data indicate the mean relative levels of mRNA from three independent experiments. Each sample was analyzed in duplicate.
(A 2A Rs and A 2B Rs), thus priming these macrophages to respond to elevated levels of extracellular adenosine [16, 17, 19] . Adenosine is a metabolite produced by cells in response to stress by breakdown of adenosine triphosphate (ATP) [25] . ATP is normally present at millimolar concentrations in cells, but in response to stress, including hypoxia and ischemia, ATP is broken down both intracellularly and following release from cells by ectonucleotidases and ectonucleosidases (CD73 and CD39) to generate adenosine [25] . Intracellular and extracellular adenosine levels are equilibrated by membrane transporters, and extracellular steady-state concentrations in response to stress can rise from low nanomolar to micromolar [25] . Adenosine then stimulates cells through the ligation of adenosine receptors, which are a family of four cell surface seven-transmembrane receptors (A1R, A 2A R, A 2B R, and A3) [26] . High extracellular adenosine levels can also be generated as a result of adenosine release from apoptotic and necrotic cells, which are a prominent component of the early wound healing environment [27, 28] . We have shown that adenosine stimulation of TLR-activated macrophages results in a switch from the production of inflammatory cytokines such as TNF-α and IL-12 to the production of anti-inflammatory and angiogenic factors, including IL-10 and VEGF [13, 17] . This model thus provides a sequential pathway whereby macrophages initially mediate inflammation through TLRdependent activation to an M1 phenotype, but are then switched into an M2d anti-inflammatory and angiogenic phenotype by adenosine generated in response to hypoxia/ischemia within the wound area. M2d macrophages, unlike previously described subsets of alternatively activated macrophages, are induced by "switching" from a classically activated inflammatory phenotype to an alternatively activated anti-inflammatory/pro-angiogenic phenotype.
We have also shown recently that adenosine signaling, through both A 2A Rs and A 2B Rs, promotes the effects of IL-4 and IL-13 in the induction of M2a activation by augmenting the expression of alternatively activated macrophage markers including arginase-1 and MGL1/CD301 [15] . The studies presented here indicate that the M2d phenotypic switch mediated by TLRs with adenosine receptors is activated independently of the canonical IL-4Rα/STAT6 "alternative activation" pathway and that macrophages activated in this way do not display the same marker profile reported previously for "alternatively activated" M2a macrophages. M2a activation is induced by signaling through the IL-4Rα/STAT6 pathway, does not involve TLR signaling, and is promoted by adenosine signaling [1, 6, 15, 29] . Here, we show that macrophages from mice lacking IL-4Rα (IL-4Rα −/− mice) respond to the TLR4 agonist LPS in a similar manner to those from WT mice in terms of their expression of TNF-α and several other inflammatory cytokines, as well as in their strong upregulation of the expression of A 2A Rs [19, 30, 31] .
IL-4Rα
−/− macrophages also respond to adenosine receptor stimulation by switching from the expression of TNF-α and IL-12 to expressing VEGF and IL-10 in a manner akin to that of WT macrophages. Previous studies from our laboratory have shown that this pathway is MyD88-, IRAK4-, and TRAF6-dependent and involves the regulation of NF-κB [17, 18, 32] . The adenosine signaling involved in this pathway modulates PLCβ2 expression and signaling rather than Gsα-dependent regulation of cAMP and involves the induction of HIF1α expression and stabilization in a hypoxia-independent manner [18, 33] . IL-4 and IFN-γ are the canonical cytokines of Th2 and Th1 responses, respectively. LPS-stimulated macrophages from IL-4Rα −/− mice express lower levels of IFN-γ than WT macrophages, indicative of their potential role in Th2 responses. In addition, IFN-γ expression by LPS-treated WT macrophages is suppressed by NECA (Fig. 2b) , also suggestive of a switch to a Th2 phenotype.
Since the adenosine-dependent switch of murine macrophages to the M2d phenotype is independent of IL-4Rα signaling, we investigated whether the expression of the canonical M2a markers Ym1, Fizz1, CD206, dectin-1, and arginase-1 is similar in M2a and M2d activation. Our results clearly indicate that, while these markers might indicate the presence of the IL-4Rα-dependent M2a macrophages in vivo, lack of expression of these markers does not indicate that populations of macrophages with an M2-like anti-inflammatory and angiogenic phenotype are absent. Arginase, Ym1, Fizz1, CD206, dectin-1, and arginase-1 are markers of murine M2a macrophages, and M2d macrophages are not identified on the basis of this marker set [5, [8] [9] [10] [11] . In contrast, expression of A 2A Rs and expression of VEGF and IL-10 are features of M2d macrophages [13, 17, 30, 31] . Expression of adenosine receptors has been demonstrated in macrophages in vitro using both ligand binding assays and qRT-PCR [16, 17] . Unfortunately, currently available antibodies to these adenosine receptors are not adequate for the identification of murine M2d macrophages either by FACS or immunohistochemistry, as they lack the required sensitivity. Further analysis of the expression of cellular markers to enable the identification of M2d macrophages in vivo is clearly required. These studies are currently underway.
Macrophage function has been shown to be integral to proper tissue repair in a number of injury models, and temporal changes in macrophage phenotype have been documented during this process [3, [34] [35] [36] . The functional phenotype of macrophage changes from the initial stage of wound debridement, through the proliferative phase of repair involving fibroblast migration, proliferation, and angiogenesis, to the later stages involving resolution of inflammation, maturation of connective tissue, regression of neovascular blood vessels, and scar formation [3, [34] [35] [36] [37] . At the outset of the healing process, classically activated (M1) macrophages predominate, suggesting a role in the clearance of apoptotic and necrotic tissue from the injured area. As healing progresses, the population shifts towards alternatively activated (M2) macrophages, suggesting a switch to the promotion of granulation tissue formation as well as to the attenuation of the inflammatory phase. In particular, macrophages are central to the development and stabilization of new blood vessels in the injured area [37] . Macrophage polarization is largely determined by local environmental signals, and dysregulation of this process severely compromises tissue repair in vivo. While the microenvironmental signals governing this process have remained largely elusive, TLR signaling has been linked to the initiation of the inflammatory response in numerous injury models. Both endogenous and exogenous TLR agonists induce "classical" M1 activation of macrophages and may play a role in wound healing [38] . The presence of "alternatively activated" M2 macrophages has been observed during the repair process; the signals involved in the induction of this phenotype have, however, not been defined [39, 40] . Significantly, macrophages expressing an M2 phenotype have been observed even in the absence of IL-4Rα/STAT6 signaling [40] . This finding strongly suggests that factors that are independent of IL-4Rα signaling play a role in the induction of multiple M2 phenotypes during tissue repair.
